Related Experiment Video
Updated: Nov 6, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Mediastinal lymphadenopathy in COVID-19: A review of literature
Pahnwat Tonya Taweesedt1, Salim Surani2
1Department of Medicine, Corpus Christi Medical Center, Corpus Christi, TX 78404, United States.
Insights
Mediastinal lymphadenopathy, or enlarged lymph nodes in the chest, is not a typical finding in COVID-19 patients. This review summarizes literature on this association, highlighting the need for further research into its significance.
Area of Science:
- Infectious Diseases
- Radiology
- Pulmonology
Background:
- Novel coronavirus disease 2019 (COVID-19) is a global pandemic causing significant morbidity and mortality.
- While pulmonary manifestations are common, COVID-19 can affect multiple organ systems, including the gastrointestinal, cardiac, and neurological systems.
- Chest imaging typically reveals bilateral lung involvement with ground-glass opacities and consolidation.
Purpose of the Study:
- To review and summarize existing literature on mediastinal lymphadenopathy in patients with COVID-19 infection.
- To investigate the suggested or observed association between COVID-19 and enlarged mediastinal lymph nodes.
- To highlight the need for further research to understand the clinical significance of this finding.
Main Methods:
- Literature review and summary of studies investigating mediastinal lymphadenopathy in COVID-19 patients.
- Analysis of reported cases and imaging findings related to mediastinal lymph node enlargement in the context of COVID-19.
- Synthesis of current understanding regarding the prevalence and potential causes of mediastinal lymphadenopathy in COVID-19.
Main Results:
- Mediastinal lymphadenopathy is not considered a typical finding on chest computed tomography (CT) in COVID-19 patients.
- Literature suggests or investigates the presence of mediastinal lymph node enlargement in some COVID-19 cases.
- The etiology of mediastinal lymphadenopathy in COVID-19 can be infectious or non-infectious, and it is often associated with other conditions like malignancy, sarcoidosis, and heart failure.
Conclusions:
- The presence of mediastinal lymphadenopathy in COVID-19 patients requires further investigation.
- Additional research is needed to better characterize the importance and implications of mediastinal lymphadenopathy in the context of COVID-19 infection.
- Understanding this association may contribute to improved diagnostic and prognostic approaches for COVID-19.
Abstract:
A novel coronavirus disease 2019 (COVID-19) is a progressive viral disease that affected people around the world with widespread morbidity and mortality. Patients with COVID-19 infection typically had pulmonary manifestation but can also present with gastrointestinal, cardiac, or neurological system dysfunction. Chest imaging in patients with COVID-19 commonly show bilateral lung involvement with bilateral ground-glass opacity and consolidation. Mediastinal lymphadenopathy can be found due to infectious or non-infectious etiologies. It is commonly found to be associated with malignant diseases, sarcoidosis, and heart failure. Mediastinal lymph node enlargement is not a typical computer tomography of the chest finding of patients with COVID-19 infection. We summarized the literature which suggested or investigated the mediastinal lymph node enlargement in patients with COVID-19 infection. Further studies are needed to better characterize the importance of mediastinal lymphadenopathy in patients with COVID-19 infection.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

